Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Thats a lot of people
The newer Foundayo (orforglipron), FDA approved April 2026, is the first oral GLP-1 with no food or water restrictions although average weight loss is lower than the injectables (11% vs 15-20%)
In addition, Indian companies have begun laying the groundwork for international expansion with Biocon partnering with Biomm who will file and commercialise their off-patent candidate in Brazil
The pharmaceutical platform Ozmosi predicts one to two GLP-1 launches annually starting in 2026
from an independent Chinese research group (PMID: 34827486) demonstrated that Dihexa rescued cognitive impairment in APP/PS1 Alzheimer's disease model mice via the PI3K/AKT signaling pathway, providing the first independent replication of cognitive enhancement effects
It aids in the breakdown of oxidized fats and is necessary for carbohydrate metabolism
US$ 24.77
US$ 25.66
US$ 21.08
